Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

被引：0
|
作者：
Yonaton Zarbiv
Yael Berner Wygoda
Albert Grinshpun
Tamar Hamburger
Tamar Sella
Shani Breuer
Ofra Maimon
Yakir Rottenberg
Tamar Peretz
Luna Kadouri
机构：
[1] Sharett Institute of Oncology,Faculty of Medicine
[2] Hadassah Medical Center,Department of Radiology
[3] The Hebrew University of Jerusalem,undefined
[4] Wohl Institute for Translational Medicine,undefined
[5] Hadassah Medical Center,undefined
[6] Hadassah Medical Center,undefined
来源：
Oncology and Therapy | 2022年 / 10卷
关键词：
Breast cancer; Recurrence; Recurrence score; BRCA1/2; Invasive lobular carcinoma; Prognostic genomic test; Predictive genomic test;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：441 / 450
页数：9
相关论文
共 50 条
  • [21] Impact of Oncotype DX Recurrence Score on Breast Cancer Prognostic Stage Group
    Breaux, Andrea C.
    Sanders, Mary Ann
    Turner, Bradley M.
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    MODERN PATHOLOGY, 2018, 31 : 52 - 52
  • [22] Impact of Oncotype DX Recurrence Score on Breast Cancer Prognostic Stage Group
    Breaux, Andrea C.
    Sanders, Mary Ann
    Turner, Bradley M.
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    LABORATORY INVESTIGATION, 2018, 98 : 52 - 52
  • [23] Oncotype DX Recurrence Score of Special Subtypes of Breast Carcinoma
    Ozerdem, Ugur
    Tavassoli, Fattaneh
    MODERN PATHOLOGY, 2017, 30 : 63A - 63A
  • [24] Oncotype DX Recurrence Score of Special Subtypes of Breast Carcinoma
    Ozerdem, Ugur
    Tavassoli, Fattaneh
    LABORATORY INVESTIGATION, 2017, 97 : 63A - 63A
  • [25] Oncotype DX Breast Recurrence Score(R): A Review of its Use in Early-Stage Breast Cancer
    Syed, Yahiya Y.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (05) : 621 - 632
  • [26] Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
    Asad, Juhi
    Jacobson, Allyson F.
    Estabrook, Alison
    Smith, Sharon Rosenbaum
    Boolbol, Susan K.
    Feldman, Sheldon M.
    Osborne, Michael P.
    Boachie-Adjei, Kwadwo
    Twardzik, Wendy
    Tartter, Paul I.
    AMERICAN JOURNAL OF SURGERY, 2008, 196 (04): : 527 - 529
  • [27] Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer.
    Chen, C.
    Patt, D. A.
    Kazzaz, D. R.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
    Andrew Dodson
    David Okonji
    Laura Assersohn
    Anne Rigg
    Amna Sheri
    Nick Turner
    Ian Smith
    Marina Parton
    Mitch Dowsett
    Breast Cancer Research and Treatment, 2018, 168 : 249 - 258
  • [29] Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
    Dodson, Andrew
    Okonji, David
    Assersohn, Laura
    Rigg, Anne
    Sheri, Amna
    Turner, Nick
    Smith, Ian
    Parton, Marina
    Dowsett, Mitch
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 249 - 258
  • [30] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    MODERN PATHOLOGY, 2012, 25 : 64A - 64A
12345